OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review
Santenna Chenchula, Krishna Chaitanya Amerneni, Mohan Krishna Ghanta, et al.
Virology (2023) Vol. 584, pp. 38-43
Open Access | Times Cited: 15

Showing 15 citing articles:

From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World
Mickensone Andre, Lee-Seng Lau, Marissa D. Pokharel, et al.
Biology (2023) Vol. 12, Iss. 9, pp. 1267-1267
Open Access | Times Cited: 39

Immunogenicity, clinical efficacy and safety of additional second COVID‐19 booster vaccines against Omicron and its subvariants: A systematic review
Santenna Chenchula, Madhu Bhargavi Chandra, Madhu Babu Adusumilli, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 5

Understanding the Omicron Variant in the COVID-19 Pandemic
Safae El Mazouri, Tarik Aanniz, Sara Louati, et al.
IntechOpen eBooks (2023)
Open Access | Times Cited: 8

Current German Recommendations and International Research on the Use of COVID-19 Boosters among Health Care Providers in 2024: A Narrative Review
Poramate Pitak‐Arnnop, Popchai Ngamskulrungroj, Nithi Mahanonda, et al.
Medicina (2024) Vol. 60, Iss. 3, pp. 385-385
Open Access | Times Cited: 1

Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins
Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 379-379
Open Access | Times Cited: 1

Global domination of the recently VoI-classified 'JN.1′ outcompeting other variants – Comparing the vaccines’ efficacy
Ranjan K. Mohapatra, Venkataramana Kandi, Abhay Gaidhane, et al.
Clinical Infection in Practice (2024) Vol. 22, pp. 100358-100358
Open Access | Times Cited: 1

A systematic review to identify novel clinical characteristics of monkeypox virus infection and therapeutic and preventive strategies to combat the virus
Santenna Chenchula, Mohan Krishna Ghanta, Krishna Chaitanya Amerneni, et al.
Archives of Virology (2023) Vol. 168, Iss. 7
Closed Access | Times Cited: 4

Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines
Keda Chen, Ling Zhang, Zhongbiao Fang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3

Evaluating mAbs Binding Abilities to Omicron Subvariant RBDs: Implications for Selecting Effective mAb Therapies
Song Luo, Danyang Xiong, Bolin Tang, et al.
Physical Chemistry Chemical Physics (2024) Vol. 26, Iss. 15, pp. 11414-11428
Closed Access

Multiomics in human viral infections
Santenna Chenchula, Kuttiappan Anitha, Satya Prakash, et al.
Elsevier eBooks (2024), pp. 145-166
Closed Access

Protein mimics of fusion core from SARS-CoV-1 can inhibit SARS-CoV-2 entry
Yancheng Zhan, Moxuan Li, Rui Gong
Biochemical and Biophysical Research Communications (2024) Vol. 736, pp. 150857-150857
Closed Access

Page 1

Scroll to top